Quadrant Capital Group’s Axonics, Inc. Common Stock AXNX Stock Holding History

Quadrant Capital Group’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-41	Closed	-$2.85K	–	2820
2024 Q3	$2.85K	Hold	41	–	–	﹤0.01%	2436
2024 Q2	$2.76K	Hold	41	–	–	﹤0.01%	2423
2024 Q1	$2.83K	Hold	41	–	–	﹤0.01%	2438
2023 Q4	$2.55K	Sell	41 -313	-88%	-$17.5K	﹤0.01%	2425
2023 Q3	$19.9K	Buy	354 +306	+638%	+$17.2K	﹤0.01%	1715
2023 Q2	$2.42K	Sell	48 -33	-41%	-$1.76K	﹤0.01%	2374
2023 Q1	$4.42K	Sell	81 -30	-27%	-$1.75K	﹤0.01%	2260
2022 Q4	$6.94K	Sell	111 -42	-27%	-$2.79K	﹤0.01%	2110
2022 Q3	$11K	Buy	153 +65	+74%	+$4.48K	﹤0.01%	1873
2022 Q2	$5K	Buy	88 +63	+252%	+$3.45K	﹤0.01%	1997
2022 Q1	$2K	Buy	+25	New	+$1.35K	﹤0.01%	2217

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Quadrant Capital Group's AXNX Position: Q4 2024 in Review

Quadrant Capital Group sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 41 shares — an estimated $2.85K sold.

Quadrant Capital Group first reported a position in AXNX in Q1 2022 and held it in 11 quarters. The position peaked at $19.9K in Q3 2023. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Quadrant Capital Group reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Quadrant Capital Group sold 41 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $2.85K.
Quadrant Capital Group first reported a position in Axonics, Inc. Common Stock in Q1 2022 and held it in 11 quarters.
Quadrant Capital Group's Axonics, Inc. Common Stock position peaked at $19.9K in Q3 2023.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Quadrant Capital Group's 13F filing for Q4 2024, filed 13 Feb 2025.